Clinical Trial Update: Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Seoul National University Hospital | Conditions: Ovarian Cancer Stage IIIC, Ovarian Cancer Stage IV | Phase 3 | Status: UNKNOWN